Showing results (991-1000 of 31,429) with videos related to
Sort By:
Pageof 3,143
Antimicrobial Agents and Chemotherapy|May 19, 2000
OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strainG Bou, A Oliver, J Martínez-BeltránAntimicrobial Agents and Chemotherapy|May 19, 2000
Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cellsK Terashi, M Oka, H Soda, et al.Antimicrobial Agents and Chemotherapy|May 19, 2000
Characterization of a Mycobacterium smegmatis mutant that is simultaneously resistant to D-cycloserine and vancomycinM Peteroy, A Severin, F Zhao, et al.Antimicrobial Agents and Chemotherapy|May 19, 2000
Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of bacteroides fragilis group: effect of the medium on test resultsD R Snydman, N V Jacobus, L A McDermott, et al.Antimicrobial Agents and Chemotherapy|May 19, 2000
Efficacy of FK463, a (1,3)-beta-D-glucan synthase inhibitor, in disseminated azole-resistant candida albicans infection in miceS Maesaki, M A Hossain, Y Miyazaki, et al.Antimicrobial Agents and Chemotherapy|November 1, 1975
Human therapeutic and agricultural uses of antibacterial drugs and resistance of the enteric flora of humansD Siegel, W G Huber, S DrysdaleAntimicrobial Agents and Chemotherapy|October 30, 1999
Activities of fluoroquinolones against Streptococcus pneumoniae type II topoisomerases purified as recombinant proteinsI Morrissey, J GeorgeAntimicrobial Agents and Chemotherapy|October 30, 1999
Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosidesJ R Aires, T Köhler, H Nikaido, et al.Antimicrobial Agents and Chemotherapy|October 30, 1999
Insertion of mini-IS605 and deletion of adjacent sequences in the nitroreductase (rdxA) gene cause metronidazole resistance in Helicobacter pylori NCTC11637Y J Debets-Ossenkopp, R G Pot, D J van Westerloo, et al.Antimicrobial Agents and Chemotherapy|October 30, 1999
Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cellsY Aoki, P N KaoPageof 3,143